Cargando…
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
It is currently estimated that 11 million Canadians are living with diabetes or prediabetes. Although hyperglycemia is associated with serious complications, it is well established that improved glycemic control reduces the risk of microvascular complications and can also reduce cardiovascular (CV)...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104258/ https://www.ncbi.nlm.nih.gov/pubmed/29476414 http://dx.doi.org/10.1007/s13300-018-0375-7 |
_version_ | 1783349452912721920 |
---|---|
author | Berard, Lori Antonishyn, Noreen Arcudi, Kathryn Blunden, Sarah Cheng, Alice Goldenberg, Ronald Harris, Stewart Jones, Shelley Mehan, Upender Morrell, James Roscoe, Robert Siemens, Rick Vallis, Michael Yale, Jean-François |
author_facet | Berard, Lori Antonishyn, Noreen Arcudi, Kathryn Blunden, Sarah Cheng, Alice Goldenberg, Ronald Harris, Stewart Jones, Shelley Mehan, Upender Morrell, James Roscoe, Robert Siemens, Rick Vallis, Michael Yale, Jean-François |
author_sort | Berard, Lori |
collection | PubMed |
description | It is currently estimated that 11 million Canadians are living with diabetes or prediabetes. Although hyperglycemia is associated with serious complications, it is well established that improved glycemic control reduces the risk of microvascular complications and can also reduce cardiovascular (CV) complications over the long term. The UKPDS and ADVANCE landmark trials have resulted in diabetes guidelines recommending an A1C target of ≤ 7.0% for most patients or a target of ≤ 6.5% to further reduce the risk of nephropathy and retinopathy in those with type 2 diabetes (T2D), if it can be achieved safely. However, half of the people with T2D in Canada are not achieving these glycemic targets, despite advances in diabetes pharmacological management. There are many contributing factors to account for this poor outcome; however, one of the major factors is the delay in treatment advancement, particularly a resistance to insulin initiation and intensification. To simplify the process of initiating and titrating insulin in T2D patients, a group of Canadian experts reviewed the evidence and best clinical practices with the goal of providing guidance and practical recommendations to the diabetes healthcare community at large. This expert panel included general practitioners (GPs), nurses, nurse practitioners, endocrinologists, dieticians, pharmacists, and a psychologist. This article summarizes the panel recommendations. |
format | Online Article Text |
id | pubmed-6104258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-61042582018-08-27 Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes Berard, Lori Antonishyn, Noreen Arcudi, Kathryn Blunden, Sarah Cheng, Alice Goldenberg, Ronald Harris, Stewart Jones, Shelley Mehan, Upender Morrell, James Roscoe, Robert Siemens, Rick Vallis, Michael Yale, Jean-François Diabetes Ther Practical Approach It is currently estimated that 11 million Canadians are living with diabetes or prediabetes. Although hyperglycemia is associated with serious complications, it is well established that improved glycemic control reduces the risk of microvascular complications and can also reduce cardiovascular (CV) complications over the long term. The UKPDS and ADVANCE landmark trials have resulted in diabetes guidelines recommending an A1C target of ≤ 7.0% for most patients or a target of ≤ 6.5% to further reduce the risk of nephropathy and retinopathy in those with type 2 diabetes (T2D), if it can be achieved safely. However, half of the people with T2D in Canada are not achieving these glycemic targets, despite advances in diabetes pharmacological management. There are many contributing factors to account for this poor outcome; however, one of the major factors is the delay in treatment advancement, particularly a resistance to insulin initiation and intensification. To simplify the process of initiating and titrating insulin in T2D patients, a group of Canadian experts reviewed the evidence and best clinical practices with the goal of providing guidance and practical recommendations to the diabetes healthcare community at large. This expert panel included general practitioners (GPs), nurses, nurse practitioners, endocrinologists, dieticians, pharmacists, and a psychologist. This article summarizes the panel recommendations. Springer Healthcare 2018-02-23 2018-04 /pmc/articles/PMC6104258/ /pubmed/29476414 http://dx.doi.org/10.1007/s13300-018-0375-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Practical Approach Berard, Lori Antonishyn, Noreen Arcudi, Kathryn Blunden, Sarah Cheng, Alice Goldenberg, Ronald Harris, Stewart Jones, Shelley Mehan, Upender Morrell, James Roscoe, Robert Siemens, Rick Vallis, Michael Yale, Jean-François Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title | Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title_full | Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title_fullStr | Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title_full_unstemmed | Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title_short | Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes |
title_sort | insulin matters: a practical approach to basal insulin management in type 2 diabetes |
topic | Practical Approach |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104258/ https://www.ncbi.nlm.nih.gov/pubmed/29476414 http://dx.doi.org/10.1007/s13300-018-0375-7 |
work_keys_str_mv | AT berardlori insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT antonishynnoreen insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT arcudikathryn insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT blundensarah insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT chengalice insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT goldenbergronald insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT harrisstewart insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT jonesshelley insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT mehanupender insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT morrelljames insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT roscoerobert insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT siemensrick insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT vallismichael insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes AT yalejeanfrancois insulinmattersapracticalapproachtobasalinsulinmanagementintype2diabetes |